Stocks · Healthcare · Biotechnology
Nuvation Bio Inc. NUVB
$5.14 -7.55% Close, Oct 2, 2026 · NYSE · Market cap $1.78B
Next earnings report: Nov 2, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $169.9M, up 1083.6% from a year earlier, slowing from 1205.5% a quarter earlier.
- Operating margin widened to -81.0% from -1564.9% a year earlier.
- The stock is 46% below its highest close of the past year.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 3%
- Revenue growth accelerationBottom 4%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 50%
- Gross marginTop 15%
- Operating marginBottom 31%
- Accruals (lower is better)Bottom 34%
- Interest coverBottom 41%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldBottom 49%
- Free-cash-flow yieldBottom 45%
- EBITDA / enterprise valueBottom 45%
- Sales / enterprise valueBottom 30%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthTop 21%
- 6-month returnTop 42%
- 1-year return vs S&P 500Top 31%
- Distance from 52-week highBottom 31%
- Trend checklist (0–4)Bottom 38%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 17%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyTop 45%
- Upside to consensus price targetTop 11%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 49%
- Maximum drawdown, 3 yearsTop 32%
- Beta vs S&P 500 (lower is better)Bottom 28%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 1205.5% | 1083.6% | ↓ |
| Gross margin | 27.5% | 93.9% | ↑ |
| Operating margin | -1564.9% | -81.0% | ↑ |
| FCF margin | -1174.4% | -71.2% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 1083.6% | 1205.5% | ↓ | Top 3% |
| Gross margin | 93.9% | 27.5% | ↑ | Top 15% |
| Operating margin | -81.0% | -1564.9% | ↑ | Bottom 31% |
| Net margin | -88.2% | -1413.4% | ↑ | — |
| Free-cash-flow margin | -71.2% | -1174.4% | ↑ | — |
| Return on invested capital | -20.7% | — | Bottom 50% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- -3.9%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- -0.2%
- Receivables growth vs revenue growthReceivables growing much faster than sales can be a warning.
- -708.6 pp
- Net debt / EBITDABelow 1× is conservative; above 3× is high leverage.
- Net cash
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -5.2×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.24%
- Shareholder yield
- -0.24%
- Share count change, 1 year
- +2.4%
- Share count change, 3-year CAGR
- +16.8%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 6, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 2 of 8
- Average EPS surprise, last 4
- +33.9%
- Average 2-day reaction, last 8
- -0.0%
- Positive 20 days after report
- 6 of 8
Analysts
- Consensus price target
- $20.50
- Target vs current price
- +298.8%
- Analysts with a rating
- 10
- Share rating Buy or Strong Buy
- 80%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 6, 2026 | -5.9% | -4.1% | +0.8% | +8.8% | — |
| May 4, 2026 | +135.7% | -1.8% | +6.7% | +10.5% | +46.8% |
| Mar 2, 2026 | +0.0% | -1.2% | -22.3% | -28.1% | -20.6% |
| Nov 3, 2025 | +5.9% | -1.0% | -9.4% | +51.0% | +2.3% |
| Aug 7, 2025 | +0.0% | -0.4% | +11.1% | +45.5% | +119.1% |
| May 7, 2025 | +0.0% | -2.4% | +4.8% | +17.2% | +6.7% |
| Mar 6, 2025 | -7.1% | +1.1% | +19.8% | -4.3% | +13.4% |
| Nov 6, 2024 | -15.4% | +9.5% | +26.3% | +18.5% | +3.9% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 6, 2026 | -$0.15 | -$0.14 | -5.9% | $31.7M |
| May 4, 2026 | $0.01 | -$0.03 | +135.7% | $83.2M |
| Mar 2, 2026 | -$0.11 | -$0.11 | +0.0% | $41.9M |
| Nov 3, 2025 | -$0.16 | -$0.17 | +5.9% | $13.1M |
| Aug 7, 2025 | -$0.17 | -$0.17 | +0.0% | $4.8M |
| May 7, 2025 | -$0.16 | -$0.16 | +0.0% | $3.1M |
| Mar 6, 2025 | -$0.15 | -$0.14 | -7.1% | $5.7M |
| Nov 6, 2024 | -$0.15 | -$0.13 | -15.4% | $727,000 |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 10.47× | — | — | Bottom 30% |
| Free-cash-flow yield | -6.78% | — | — | Bottom 45% |
| Earnings yield | -8.48% | — | — | Bottom 49% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✓ 50-day average above 200-day
- ✗ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- +0.3%
- 200-day average slope (20 days)
- -2.8%
- Distance from 50-day average
- -19.0%
- Distance from 200-day average
- -11.0%
- RSI (14)
- 29.1
- Relative volume
- 3.17×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 56.3%
- Volatility vs own 5-year history
- 17th percentile · Low for this stock
- Beta vs S&P 500 (2 years, weekly)
- 1.62
- Correlation with S&P 500
- 0.29
- Current drawdown from 1-year high
- -46.1%
- Maximum drawdown, 3 years
- -58.2%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Mar 19, 2021 | Oct 31, 2023 | -93.4% | 659 days | Not yet recovered |
| Jan 5, 2021 | Feb 12, 2021 | -23.7% | 27 days | 16 days (Mar 9, 2021) |
| Sep 25, 2020 | Dec 2, 2020 | -12.3% | 47 days | 20 days (Dec 31, 2020) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $1.78B
- EPS, diluted (TTM)
- -$0.44
- Revenue (TTM)
- $169.9M
- 52-week range
- $3.36 – $9.75
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $7.9M | $62.9M |
| Gross profit | $0 | $0 | $0 | $795,000 | $54.5M |
| Operating income | -$93.3M | -$119.7M | -$99.8M | -$592.6M | -$213.1M |
| Net income | -$86.8M | -$104.2M | -$75.8M | -$567.9M | -$204.6M |
| EPS (diluted) | -$0.44 | -$0.48 | -$0.35 | -$2.11 | -$0.60 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $727,000 | $5.7M | $3.1M | $4.8M | $13.1M | $41.9M | $83.2M | $31.7M |
| Net income | -$41.2M | -$49.4M | -$53.2M | -$59.0M | -$55.8M | -$36.6M | $5.4M | -$62.8M |
| EPS (diluted) | -$0.15 | -$0.15 | -$0.16 | -$0.17 | -$0.16 | -$0.11 | $0.01 | -$0.18 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$68.2M | -$96.1M | -$68.0M | -$130.4M | -$173.4M |
| Capital expenditure | -$282,000 | -$370,000 | -$69,000 | -$162,000 | -$354,000 |
| Free cash flow | -$68.5M | -$96.5M | -$68.1M | -$130.6M | -$173.8M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $0 | $0 | $0 | $4.9M | $11.4M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $661.0M
- Total assets
- $744.5M
- Total liabilities
- $490.6M
- Total debt
- $252.1M
- Net debt
- -$6.5M
- Shareholders’ equity
- $253.9M
As of Jun 30, 2026 (filed Aug 6, 2026).
Short interest
- Shares sold short
- 58,173,586
- Days to cover
- 10.89
- Change vs previous report
- +7.2%
FINRA short interest, settlement date Sep 15, 2026.